Eugene A. Woltering

5.9k total citations
162 papers, 4.5k citations indexed

About

Eugene A. Woltering is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Eugene A. Woltering has authored 162 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Epidemiology, 73 papers in Oncology and 54 papers in Neurology. Recurrent topics in Eugene A. Woltering's work include Neuroendocrine Tumor Research Advances (86 papers), Neuroblastoma Research and Treatments (52 papers) and Lung Cancer Research Studies (44 papers). Eugene A. Woltering is often cited by papers focused on Neuroendocrine Tumor Research Advances (86 papers), Neuroblastoma Research and Treatments (52 papers) and Lung Cancer Research Studies (44 papers). Eugene A. Woltering collaborates with scholars based in United States, United Kingdom and Australia. Eugene A. Woltering's co-authors include Thomas M. O’Dorisio, Martyn Caplin, Lowell Anthony, J. Philip Boudreaux, William S. Fletcher, Catherine T. Anthony, Yi‐Zarn Wang, Larry K. Kvols, Gregory D. Espenan and Aaron I. Vinik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Eugene A. Woltering

159 papers receiving 4.3k citations

Peers

Countries citing papers authored by Eugene A. Woltering

Since Specialization

Citations

This map shows the geographic impact of Eugene A. Woltering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene A. Woltering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene A. Woltering more than expected).

Fields of papers citing papers by Eugene A. Woltering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene A. Woltering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene A. Woltering. The network helps show where Eugene A. Woltering may publish in the future.

Co-authorship network of co-authors of Eugene A. Woltering

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene A. Woltering. A scholar is included among the top collaborators of Eugene A. Woltering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene A. Woltering. Eugene A. Woltering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Plasma Pancreastatin in Predicting Prognosis Following R0/R1 Surgical Cytoreduction in Small Bowel Neuroendocrine Tumors 2019 ·Pancreas ·Eugene A. Woltering, (unknown), Ramcharan Thiagarajan, (unknown), Robert A. Ramirez, Gregg Mamikunian, J. Philip Boudreaux	1
2	Reappraisal of lymphatic mapping for midgut neuroendocrine patients undergoing cytoreductive surgery 2014 ·Surgery ·Yi‐Zarn Wang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eugene A. Woltering	15
3	Cervical and Upper Mediastinal Lymph Node Metastasis from Gastrointestinal and Pancreatic Neuroendocrine Tumors: True Incidence and Management 2012 ·Journal of the American College of Surgeons ·Yi‐Zarn Wang, (unknown), Lowell Anthony, Richard J. Campeau, (unknown), Eugene A. Woltering	4
4	Validation of Neurokinin A Assays in the United States and Europe 2011 ·Pancreas ·(unknown), Joy Ardill, Thomas M. O’Dorisio, S Krutzik, Aaron I. Vinik, Vay Liang W. Go, (unknown), Gregg Mamikunian, Eugene A. Woltering	12
5	Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior 2010 ·Pancreas ·Thomas M. O’Dorisio, S Krutzik, Eugene A. Woltering, (unknown), Saju Joseph, (unknown), (unknown), (unknown), Aaron I. Vinik, Vay Liang W. Go, James R. Howe, (unknown), M. Sue O’Dorisio, Gregg Mamikunian	37
6	Neuroendocrine Tumors 2010 ·Pancreas ·Aaron I. Vinik, Lowell Anthony, J. Philip Boudreaux, Vay Liang W. Go, Thomas M. O’Dorisio, Philippe Ruszniewski, Eugene A. Woltering	18
7	The Role of VEGF Pathways in Human Physiologic and Pathologic Angiogenesis 2009 ·Journal of Surgical Research ·John Lyons, (unknown), Catherine T. Anthony, Jessica L. Thomson, (unknown), (unknown), (unknown), Paul R. Kucera, Yi‐Zarn Wang, J. Philip Boudreaux, Eugene A. Woltering	19
8	Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors 2008 ·Cancer Biotherapy and Radiopharmaceuticals ·Ebrahim S. Delpassand, Jennifer Sims‐Mourtada, Hitomi Saso, Ali Azhdarinia, Faramarz Ashoori, (unknown), Gregory D. Espenan, Warren H. Moore, Eugene A. Woltering, Lowell Anthony	40
9	The Safety and Efficacy of a Dietary Herbal Supplement and Gallic Acid for Weight Loss 2007 ·Journal of Medicinal Food ·(unknown), Corby K. Martin, Zhijun Liu, (unknown), Eugene A. Woltering, Jennifer Rood, (unknown), Ying Yu, Hui Xie, Frank L. Greenway	50
10	Development of a Human Cardiac Tissue-Based Angiogenesis Model 2006 ·Journal of Surgical Research ·James M. Lewis, Catherine T. Anthony, Lynn Harrison, T. Bruce Ferguson, (unknown), (unknown), Douglas A. Balster, Eugene A. Woltering	3
11	Effect of Human Angiostatin® Protein on Human Angiogenesis in vitro 2003 ·Angiogenesis ·(unknown), (unknown), Yi‐Zarn Wang, Mark Wade, Catherine T. Anthony, Conrad A. Hornick, Eugene A. Woltering	8
12	Development of a Novel In Vitro Human Tissue-Based Angiogenesis Assay to Evaluate the Effect of Antiangiogenic Drugs 2003 ·Annals of Surgery ·Eugene A. Woltering, James M. Lewis, P Maxwell, Daniel Frey, Yi-Zarn Wang, J. D. Rothermel, Catherine T. Anthony, Douglas A. Balster, J. Patrick O’Leary, Lynn Harrison	28
13	Progressive nuclear translocation of somatostatin analogs. 2000 ·PubMed ·Conrad A. Hornick, Catherine T. Anthony, (unknown), Bryan M. Gebhardt, Gregory D. Espenan, Eugene A. Woltering	46
14	Multiply Radioiodinated Somatostatin Analogs Induce Receptor-Specific Cytotoxicity 1998 ·Journal of Surgical Research ·Michael C. Meyers, Catherine T. Anthony, D.H. Coy, William A. Murphy, (unknown), Joseph A. Fuselier, Gregory D. Espenan, Thomas J. Maloney, Eugene A. Woltering	11
15	Intravitreal Injection of Octreotide Acetate 1997 ·Journal of Ocular Pharmacology and Therapeutics ·(unknown), (unknown), Eugene A. Woltering, (unknown), Rosemary Barrie, Thomas M. O’Dorisio, Douglas Holmes	9
16	Calcium Reverses Octreotide Inhibition of Insulin and Glucagon Levels in Patients with Insulinoma and Glucagonoma 1996 ·Digestion ·Courtney S. Thompson, Thomas M. O’Dorisio, Eugene A. Woltering	6
17	Synergistic cytotoxicity of DMSO-antineoplastic combinations against P388 leukemia in CD-F1 mice 1988 ·Rodney F. Pommier, Eugene A. Woltering, William S. Fletcher	4
18	Cytotoxicity of dimethyl sulfoxide and antineoplastic combinations against human tumors 1988 ·The American Journal of Surgery ·Rodney F. Pommier, Eugene A. Woltering, (unknown), William S. Fletcher	7
19	Synergistic cytotoxicity between dimethyl sulfoxide and antineoplastics against ovarian cancer in vitro 1987 ·Rodney F. Pommier, Eugene A. Woltering, (unknown), William S. Fletcher	2
20	Evaluation of Bupivacaine Nerve Blocks in the Modification of Pain and Pulmonary Function Changes after Thoracotomy 1980 ·The Annals of Thoracic Surgery ·Eugene A. Woltering, M. Wayne Flye, (unknown), (unknown), Andrew Dwyer, Byron D. McLees	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact